[go: up one dir, main page]

EA002481B1 - Композиция на основе солюбилизированного сертралина - Google Patents

Композиция на основе солюбилизированного сертралина Download PDF

Info

Publication number
EA002481B1
EA002481B1 EA199900962A EA199900962A EA002481B1 EA 002481 B1 EA002481 B1 EA 002481B1 EA 199900962 A EA199900962 A EA 199900962A EA 199900962 A EA199900962 A EA 199900962A EA 002481 B1 EA002481 B1 EA 002481B1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
sertraline
solubilizing agent
concentration
matter
Prior art date
Application number
EA199900962A
Other languages
English (en)
Russian (ru)
Other versions
EA199900962A1 (ru
Inventor
Дуэйн Томас Фризен
Скотт Макс Хербиг
Рави Майсор Шенкер
Джеймс Блэр Вест
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA002481(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA199900962A1 publication Critical patent/EA199900962A1/ru
Publication of EA002481B1 publication Critical patent/EA002481B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EA199900962A 1997-07-01 1998-06-15 Композиция на основе солюбилизированного сертралина EA002481B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (2)

Publication Number Publication Date
EA199900962A1 EA199900962A1 (ru) 2000-08-28
EA002481B1 true EA002481B1 (ru) 2002-06-27

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900962A EA002481B1 (ru) 1997-07-01 1998-06-15 Композиция на основе солюбилизированного сертралина

Country Status (34)

Country Link
EP (1) EP0999829A1 (es)
JP (1) JP2000514100A (es)
KR (1) KR100366373B1 (es)
CN (1) CN1261794A (es)
AP (1) AP1192A (es)
AR (3) AR015917A1 (es)
AU (1) AU742535B2 (es)
BG (1) BG103918A (es)
BR (1) BR9810739A (es)
CA (1) CA2290974C (es)
CO (1) CO4940495A1 (es)
DZ (1) DZ2548A1 (es)
EA (1) EA002481B1 (es)
HN (1) HN1998000102A (es)
HR (1) HRP980377A2 (es)
HU (1) HUP0002236A3 (es)
ID (1) ID23429A (es)
IL (1) IL133076A (es)
IS (1) IS5260A (es)
MA (1) MA24587A1 (es)
NO (1) NO996520L (es)
OA (1) OA11243A (es)
PA (1) PA8454301A1 (es)
PE (1) PE97199A1 (es)
PL (1) PL337804A1 (es)
SK (1) SK181099A3 (es)
TN (1) TNSN98124A1 (es)
TR (1) TR199903297T2 (es)
TW (1) TW550087B (es)
UA (1) UA67741C2 (es)
UY (1) UY25071A1 (es)
WO (1) WO1999001120A1 (es)
YU (1) YU68299A (es)
ZA (1) ZA985708B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
WO2002017918A2 (en) 2000-08-30 2002-03-07 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
KR101500020B1 (ko) * 2007-03-12 2015-03-06 디에스엠 아이피 어셋츠 비.브이. 미용 조성물
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
EP2520300A4 (en) * 2009-12-29 2013-05-08 Kowa Co PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺
CN114894736A (zh) * 2022-05-20 2022-08-12 中化地质矿山总局地质研究院 一种氯化物型卤水中硝酸根的测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
MA24587A1 (fr) 1998-12-31
UY25071A1 (es) 2000-12-29
OA11243A (en) 2003-07-24
UA67741C2 (uk) 2004-07-15
AR015917A1 (es) 2001-05-30
EP0999829A1 (en) 2000-05-17
WO1999001120A1 (en) 1999-01-14
PE97199A1 (es) 1999-10-05
IL133076A (en) 2003-12-10
HUP0002236A3 (en) 2003-12-29
EA199900962A1 (ru) 2000-08-28
CA2290974A1 (en) 1999-01-14
AU742535B2 (en) 2002-01-03
PA8454301A1 (es) 2000-09-29
BG103918A (en) 2000-07-31
TR199903297T2 (xx) 2000-07-21
PL337804A1 (en) 2000-09-11
DZ2548A1 (fr) 2003-02-08
AR040280A2 (es) 2005-03-23
JP2000514100A (ja) 2000-10-24
YU68299A (sh) 2002-06-19
ZA985708B (en) 2000-01-10
IS5260A (is) 1999-11-19
CO4940495A1 (es) 2000-07-24
BR9810739A (pt) 2000-09-12
KR20010013365A (ko) 2001-02-26
HUP0002236A2 (hu) 2003-08-28
AR040279A2 (es) 2005-03-23
CA2290974C (en) 2004-04-27
AP9801280A0 (en) 1998-06-30
TW550087B (en) 2003-09-01
SK181099A3 (en) 2000-07-11
NO996520L (no) 2000-02-29
HN1998000102A (es) 1999-01-08
IL133076A0 (en) 2001-03-19
TNSN98124A1 (fr) 2005-03-15
NO996520D0 (no) 1999-12-28
AP1192A (en) 2003-07-23
KR100366373B1 (ko) 2003-01-14
ID23429A (id) 2000-04-20
HRP980377A2 (en) 1999-04-30
AU7544898A (en) 1999-01-25
CN1261794A (zh) 2000-08-02

Similar Documents

Publication Publication Date Title
ES2226886T3 (es) Forma de administracion de accion retardada que contiene sacarinato de tramadol.
KR880001090B1 (ko) 디피리다몰의 경구용 제형의 제조방법
US6117453A (en) Solid compositions containing polyethylene oxide and an active ingredient
AU760006B2 (en) Method for making granules with masked taste and instant release of the active particle
US20110129539A1 (en) Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillin
KR20180073665A (ko) 심혈관 질환의 치료를 위한 젬카빈 조합
RU2377976C2 (ru) ФАРМАЦЕВТИЧЕСКАЯ МНОГОСЛОЙНАЯ ТАБЛЕТКА ДЛЯ КОНТРОЛИРУЕМОГО ВЫСВОБОЖДЕНИЯ АКТИВНЫХ ИНГРЕДИЕНТОВ С РАСТВОРИМОСТЬЮ, В ВЫСОКОЙ СТЕПЕНИ ЗАВИСЯЩЕЙ ОТ pH
CZ288598B6 (cs) Třífázová farmaceutická forma s konstantním a řízeným uvolňováním amorfní účinné složky a způsob její přípravy
PT2079446E (pt) Formulação de libertação sustida de paliperidona
JPWO2005092336A1 (ja) 溶出制御製剤とその製造方法
NL8203343A (nl) Farmaceutisch preparaat.
EA002481B1 (ru) Композиция на основе солюбилизированного сертралина
EA001906B1 (ru) Лекарственные формы с замедленным высвобождением сертралина
JP2002509887A (ja) セファクロル含有徐放性組成物
ES2321908T3 (es) Preparaciones farmaceuticas de liberacion prolongada independientemente del ph.
EP0983065A1 (fr) Composition pharmaceutique a residence gastrique
JPH04234812A (ja) 持続性製剤用顆粒
EA028481B1 (ru) Препараты производных пиримидиндиона
EP0447168A2 (en) Long acting granular pharmaceutical composition
IE57220B1 (en) Ph independent controlled releasable tablets
WO2007003746A1 (fr) Formulation a liberation prolongee de principes actifs presentant une solubilite dependante du ph
US20040208926A1 (en) Solubilized sertraline compositions
EP1895990A2 (en) Formulations containing pantoprazole free acid and its salts
CA2635949A1 (en) Controlled release formulation of divalproic acid and its derivatives
NZ501250A (en) Solubilized sertraline compositions